Deborah J Andrews - Net Worth and Insider Trading
Deborah J Andrews Net Worth
The estimated net worth of Deborah J Andrews is at least $2 Million dollars as of 2024-04-25. Deborah J Andrews is the CFO of Staar Surgical Co and owns about 31,267 shares of Staar Surgical Co (STAA) stock worth over $1 Million. Deborah J Andrews is also the Director of Lineage Cell Therapeutics Inc and owns about 10,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $11,000. Details can be seen in Deborah J Andrews's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Deborah J Andrews has not made any transactions after 2020-03-23 and currently still holds the listed stock(s).
Transaction Summary of Deborah J Andrews
Deborah J Andrews Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deborah J Andrews owns 2 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , and Staar Surgical Co (STAA) .
Click here to see the complete history of Deborah J Andrews’s form 4 insider trades.
Insider Ownership Summary of Deborah J Andrews
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2018-09-11 | director |
| STAA | Staar Surgical Co | 2020-03-23 | VP & Chief Financial Officer |
Deborah J Andrews Latest Holdings Summary
Deborah J Andrews currently owns a total of 2 stocks. Among these stocks, Deborah J Andrews owns 31,267 shares of Staar Surgical Co (STAA) as of March 23, 2020, with a value of $1 Million and a weighting of 99.27%. Deborah J Andrews also owns 10,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of September 11, 2018, with a value of $11,000 and a weighting of 0.73%.
Latest Holdings of Deborah J Andrews
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STAA | Staar Surgical Co | 2020-03-23 | 31,267 | 47.82 | 1,495,188 |
| LCTX | Lineage Cell Therapeutics Inc | 2018-09-11 | 10,000 | 1.10 | 11,000 |
Holding Weightings of Deborah J Andrews
Deborah J Andrews Form 4 Trading Tracker
According to the SEC Form 4 filings, Deborah J Andrews has made a total of 3 transactions in Staar Surgical Co (STAA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Staar Surgical Co is the sale of 834 shares on March 23, 2020, which brought Deborah J Andrews around $22,868.
According to the SEC Form 4 filings, Deborah J Andrews has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 1,604 shares on September 11, 2018, which cost Deborah J Andrews around $3,769.
Insider Trading History of Deborah J Andrews
- 1
Deborah J Andrews Trading Performance
GuruFocus tracks the stock performance after each of Deborah J Andrews's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deborah J Andrews is -8.01%. GuruFocus also compares Deborah J Andrews's trading performance to market benchmark return within the same time period. The performance of stocks bought by Deborah J Andrews within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deborah J Andrews's insider trading performs compared to the benchmark.
Performance of Deborah J Andrews
Average Return
-18.69%
Outperforming Transactions
20%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.14 | -8.01 | -16.58 | -18.69 | -28.86 | -16.99 |
| Relative Return to S&P 500(%) | 4.26 | -10.32 | -21.72 | -30.93 | -38.44 | -28.22 |
Deborah J Andrews Ownership Network
Ownership Network List of Deborah J Andrews
Ownership Network Relation of Deborah J Andrews
Deborah J Andrews Owned Company Details
What does Lineage Cell Therapeutics Inc do?
Who are the key executives at Lineage Cell Therapeutics Inc?
Deborah J Andrews is the director of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include 10 percent owner Broadwood Partners Lp , Chief Financial Officer Jill Ann Howe , and director & President and CEO Brian M Culley .
Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary
Over the past 18 months, Deborah J Andrews made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 96,155 shares made by Don M Bailey , and a net purchase of 10,000 shares made by Anula Jayasuriya .
In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 6,826,925 shares, with a net purchase of 6,826,925 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,836,925 shares were bought by its insiders, resulting in a net purchase of 6,836,925 shares.
Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lineage Cell Therapeutics Inc Insider Transactions
Deborah J Andrews Mailing Address
Above is the net worth, insider trading, and ownership report for Deborah J Andrews. You might contact Deborah J Andrews via mailing address: 1911 Walker Ave., Monrovia Ca 91016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
